Michael Kabesch

Prof. Michael Kabesch


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2006 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
MKMichael Kabesch
Michael Kabesch
MSMichaela Schedel
Michaela Schedel
DCDavid John Carr
David John Carr
BWBernd Woitsch
Bernd Woitsch
CFChristian Fritzsch
Christian Fritzsch
EMErika von Mutius
Erika von Mutius

25 January 2013 in Allergy
Verified
Journal Article
Closed access
PDF file
SMS. Michel
S. Michel
FBF. Busato
F. Busato
JGJon Genuneit
Jon Genuneit
JPJ. Pekkanen
J. Pekkanen
JDJ.‐C. Dalphin
J.‐C. Dalphin
TGthe PASTURE study group
the PASTURE study group

14 February 2020 in Seminars in Immunopathology
Verified
Journal Article
Open access
PDF file
MKMichael Kabesch
Michael Kabesch
Jorg TostJorg Tost
Jorg Tost
In asthma and allergy genetics, a trend towards a few main topics developed over the last 2 years. First, a number of studies have been published recently which focus on overlapping and/or very specific phenotypes: within the allergy spectrum but also reaching beyond, looking for common genetic traits shared between different diseases or disease entities. Secondly, an urgently needed focus has been put on asthma and allergy genetics in populations genetically different from European ancestry. This acknowledges that the majority of new asthma patients today are not white and asthma is a truly worldwide disease. In epigenetics, recent years have seen several large-scale epigenome-wide association studies (EWAS) being published and a further focus was on the interaction between the environment and epigenetic signatures. And finally, the major trends in current asthma and allergy genetics and epigenetics comes from the field of pharmacogenetics, where it is necessary to understand the susceptibility for and mechanisms of current asthma and allergy therapies while at the same time, we need to have scientific answers to the recent availability of novel drugs that hold the promise for a more individualized therapy.

1 October 2015 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
MSMichaela Schedel
Michaela Schedel
SMSven Michel
Sven Michel
VGVincent D. Gaertner
Vincent D. Gaertner
ATAntoaneta A. Toncheva
Antoaneta A. Toncheva
MDMartin Depner
Martin Depner
MKMichael Kabesch
Michael Kabesch

1 March 2013 in Allergy
Verified
Journal Article
Closed access
PDF file
JRJ. S. Ried
J. S. Ried
HBHansjörg Baurecht
Hansjörg Baurecht
FSF. Stückler
F. Stückler
JKJ. Krumsiek
J. Krumsiek
CGC. Gieger
C. Gieger
SWS. Weidinger
S. Weidinger

17 May 2021 in European Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
SBSusanne Brandstetter
Susanne Brandstetter
MBMerle Margarete Böhmer
Merle Margarete Böhmer
MPMaja Pawellek
Maja Pawellek
BSBirgit Seelbach-Göbel
Birgit Seelbach-Göbel
MMMichael Melter
Michael Melter
SWSven Wellmann
Sven Wellmann
A COVID-19 vaccine can be an important key for mitigating the spread of the pandemic, provided that it is accepted by a sufficient proportion of the population. This study investigated parents’ intention to get vaccinated and to have one’s child vaccinated against COVID-19. In May 2020, 612 parents participating with their child in the KUNO-Kids health study completed an online survey. Multivariable logistic regression models were calculated to analyze predictors of intention to vaccinate. Fifty-eight percent of parents intended to get vaccinated against COVID-19, and 51% intended to have their child vaccinated. Significant predictors for the intention to get vaccinated and for having the child vaccinated included stronger parental confidence in one’s knowledge about prevention measures and lower beliefs that policy measures were exaggerated.Conclusion: COVID-19 vaccination hesitancy was considerable in our sample of parents in Germany. However, our study revealed some potentially modifiable factors which should be addressed by a comprehensive and tailored communication and education strategy. What is Known?• A COVID-19 vaccine can mitigate the spread of the pandemic.• Many parents are skeptical about vaccinations in general. What is New?• COVID-19 vaccination hesitancy was considerable in our sample of parents from Germany, not only for getting vaccinated but also for having the child vaccinated.• Negative parental attitudes regarding policy measures to contain the pandemic were associated with a lower intention to vaccinate.